Pfizer Zyvox Study Of Catheter-Related Infections May Lower Enrollment Goal
Executive Summary
Pfizer may change its enrollment goal for a Zyvox study depending on FDA's modification of its 1999 guidance on catheter-related bloodstream infections (CRBSI)